EIF2AK3 and breast carcinoma: Importantly, the RNA sequencing data on ERO1 KO MDAMB23* breast cancer indicate an increase in UPR and specifically in ER‐resident kinase PERK (eIF2AK3) branch, suggesting activation of the PERK arm of the UPR.